CancerDotNet

@AmericanCancer and @ASCO are uniting to educate and empower patients. Visit can't answer individual medical questions.

Retweet ≠Endorsement

[CancerDotNet @CancerDotNet]

We’re expanding our collaboration w/ @AmericanCancer to create an online resource for people w/ cancer. Starting 6/3, https://t.co/z7njHqlfPw will redirect to https://t.co/JSzwyLYuvl for comprehensive content from ACS & @ASCO. Read more: https://t.co/nUlSsszXKF #ASCO24

[CancerDotNet @CancerDotNet]

Breaking #ASCO24 news! Study summary for patients: Docetaxel chemotherapy causes less peripheral #Neuropathy than paclitaxel chemotherapy for Black people with early-stage #BreastCancer #BCSM https://t.co/4JG6O6GB7n

[CancerDotNet @CancerDotNet]

New! #ASCO24 study summary for patients: Trastuzumab deruxtecan slows cancer growth for people with HR+, HER2-low or HER2-ultralow #MetastaticBreastCancer that has grown following endocrine therapy #MBC #BCSM #BreastCancer https://t.co/naZGbFQeQB

[CancerDotNet @CancerDotNet]

New! #ASCO24 study summary for patients: Adding belantamab mafodotin to #MultipleMyeloma treatment combinations appears to be more effective at stopping relapsed disease than current standard treatments #HemOnc https://t.co/oa1hy89eSV

[CancerDotNet @CancerDotNet]

New! #ASCO24 study summary for patients: Some people with advanced #OvarianCancer may safely avoid having their lymph nodes removed during cancer surgery without it impacting survival https://t.co/IdxXWCObpf #GYNCSM #OVCSM

[CancerDotNet @CancerDotNet]

Breaking #ASCO24 news! Study summary for patients: Durvalumab after chemoradiotherapy helps people with limited-stage small cell #LungCancer live longer #SCLC #LCSM https://t.co/7wCFb3Z7QK

[CancerDotNet @CancerDotNet]

New! #ASCO24 #LAURA study summary for patients: Osimertinib after chemoradiotherapy improves progression-free survival (#PFS) for people with unresectable stage III #EGFRm #NSCLC #LCSM https://t.co/5xXE9fV8YZ

[CancerDotNet @CancerDotNet]

New! #ASCO24 study summary for patients: Neoadjuvant #Immunotherapy given for stage III #Melanoma, followed by adjuvant therapy only if there is not a deep response to treatment, improves outcomes for patients #MelSM https://t.co/uW9U69hELS

[CancerDotNet @CancerDotNet]

Breaking #ASCO24 news study summary for patients: Chemotherapy before and after surgery improves survival for people with locally advanced #esophageal adenocarcinoma #EsophagealCancer https://t.co/5vmoY2YhQQ

[CancerDotNet @CancerDotNet]

New from #ASCO24! Study summary for patients: Telehealth #palliative care program is as effective as an in-person palliative care program for people with advanced #LungCancer #LCSM #PallOnc https://t.co/zq0lbFHEnw

[CancerDotNet @CancerDotNet]

Breaking #ASCO24 news! Study summary for patients: New treatment combination cures classical #Hodgkin lymphoma more effectively and with fewer side effects than an established intensive chemotherapy regimen https://t.co/jvYM9TaHkk #lymsm

[CancerDotNet @CancerDotNet]

New! #ASCO24 study summary for patients: Lorlatinib can help people with advanced ALK-positive non-small cell #LungCancer who have not yet received treatment live longer without disease progression and prevent brain metastases in some patients https://t.co/FslAPyHcAZ #NSCLC #LCSM

[CancerDotNet @CancerDotNet]

New! #ASCO24 study summary for patients: Asciminib appears to be a safe and effective treatment option for people recently diagnosed with chronic phase chronic myeloid #Leukemia #CML #LeuSM https://t.co/uEuQlIyhHB

[CancerDotNet @CancerDotNet]

New! #ASCO24 study summary for patients: The #HPV vaccine lowers the risk of developing HPV-related cancers in men and women, especially #HeadandNeckCancer in men and #CervicalCancer in women https://t.co/UbmMxYEtKk #GYNCSM #HNCSM #CancerPrevention

[CancerDotNet @CancerDotNet]

New! #ASCO24 study summary for patients: Most #BreastCancer survivors trying to conceive are successful in becoming pregnant and giving birth https://t.co/LVIXZEZLaN #BCSM #Fertility #CancerSurvivorship #CancerandPregnancy

[CancerDotNet @CancerDotNet]

New! #ASCO24 study summary for patients: #AI-based patient navigation tool may help encourage people in underserved communities receive #ColorectalCancer screening, which can help reduce #CancerDisparities in these patients https://t.co/q9Hr8KuiQN #HealthEquity #CancerScreening

[CancerDotNet @CancerDotNet]

New! #ASCO24 study summary for patients: Estrogen-only menopausal hormone therapy may increase the risk of #OvarianCancer, while combined therapy may not impact this risk and may lower the risk of #UterineCancer https://t.co/8tLohlUHKt #GYNCSM #Menopause

[CancerDotNet @CancerDotNet]

🌟 Discover the inspiring story of Mardie Caldwell Christensen and her granddaughter Ellie as they navigate #ChildhoodCancer. From navigating treatments to finding joy amid challenges, their story is a testament to resilience and hope. #EllieTheBrave
https://t.co/VqbopVfgWI

[CancerDotNet @CancerDotNet]

Meet David M. Klaus, a courageous #BladderCancer #Survivor. Read his empowering story of strength and hope and the 7 things he learned during his #CancerTreatment.
https://t.co/9K4RkzpOld

[CancerDotNet @CancerDotNet]

Balancing work & #Caring for a loved one with #Cancer can be challenging. Gain insights from @cancerrights attorney, Joanna Doran, Esq. on navigating this important role as #Caregiver. Read this blog post for actionable tips & helpful resources.
https://t.co/wa6w2kvqPj